LIKMEZ
Growthmetronidazole oral
NDAORALSUSPENSION
Approved
Sep 2023
Lifecycle
Growth
Competitive Pressure
0/100
Mechanism of Action
12.1 Mechanism of Action Metronidazole is a nitroimidazole antimicrobial drug [ see ] . 12.3 Pharmacokinetics Metronidazole pharmacokinetics are similar for both oral and intravenous dosage forms. The C max is dose proportional between 250 mg, 500 mg, and 2,000 mg for metronidazole oral tablets,…
Pharmacologic Class:
Nitroimidazole Antimicrobial
Indications (7)
acute intestinal amebiasis (amoebic dysentery)amebic liver abscess in adultsthe treatment of the following serious infections caused by susceptible anaerobic bacteria in adults: Intra-abdominal infectionsincluding peritonitisintra-abdominal abscessliver abscesscaused by Bacteroides species including the B
Loss of Exclusivity
LOE Date
Oct 4, 2039
165 months away
Patent Expiry
Oct 4, 2039